Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Cash Flow Quality Index
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Cash Flow Quality Index of 1.48x as of December 2024. Operating cash flow of CN¥116.38 Million exceeds net income of CN¥78.85 Million, indicating high earnings quality where cash backs reported profits. Also explore Medprin Regenerative Medical Technologie balance sheet assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Medprin Regenerative Medical Technologie to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year earnings quality comparison for Medprin Regenerative Medical Technologies Co. Ltd.. For live market cap and the full company financial profile, see how much is Medprin Regenerative Medical Technologie worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.48x | CN¥116.38 Million | CN¥78.85 Million | ▼ -44.0% |
| 2023 | 2.63x | CN¥107.69 Million | CN¥40.88 Million | ▲ +95.7% |
| 2022 | 1.35x | CN¥48.31 Million | CN¥35.89 Million | ▼ -9.5% |
| 2021 | 1.49x | CN¥66.51 Million | CN¥44.73 Million | ▲ +62.1% |
| 2020 | 0.92x | CN¥33.91 Million | CN¥36.97 Million | ▼ -18.8% |
| 2019 | 1.13x | CN¥31.27 Million | CN¥27.68 Million | — |